These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31367607)

  • 1. Acute Hair Loss 3 Years after Bone Marrow Transplant.
    Silva L; De Fraia Souza MN; Teixeira S; Sternberg F; Dumet Fernandes J
    Skin Appendage Disord; 2019 Jun; 5(4):255-258. PubMed ID: 31367607
    [No Abstract]   [Full Text] [Related]  

  • 2. CD56
    Kariminia A; Ivison S; Ng B; Rozmus J; Sung S; Varshney A; Aljurf M; Lachance S; Walker I; Toze C; Lipton J; Lee SJ; Szer J; Doocey R; Lewis I; Smith C; Chaudhri N; Levings MK; Broady R; Devins G; Szwajcer D; Foley R; Mostafavi S; Pavletic S; Wall DA; Couban S; Panzarella T; Schultz KR
    Haematologica; 2017 Nov; 102(11):1936-1946. PubMed ID: 28935847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease.
    Marks DH; Naftulin JS; Penzi LR; Manatis-Lornell A; Yasuda MR; Chapman CM; Rao SR; Saavedra A; Senna MM
    J Am Acad Dermatol; 2019 Nov; 81(5):1134-1141. PubMed ID: 31454500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.
    Anasetti C; Beatty PG; Storb R; Martin PJ; Mori M; Sanders JE; Thomas ED; Hansen JA
    Hum Immunol; 1990 Oct; 29(2):79-91. PubMed ID: 2249952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous manifestations of chronic graft-versus-host disease.
    Andrews ML; Robertson I; Weedon D
    Australas J Dermatol; 1997 May; 38(2):53-62; quiz 63-4. PubMed ID: 9159958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of GSTO2 (N142D), GSTT1, and GSTM1 Polymorphisms With Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Khosravi M; Izaddoust M; Saadat I; Karimi MH; Ramzi M
    Exp Clin Transplant; 2016 Aug; 14(4):436-40. PubMed ID: 26103006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IFN-gamma allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplant.
    Karimi MH; Daneshmandi S; Pourfathollah AA; Geramizadeh B; Ramzi M; Yaghobi R; Ebadi P
    Exp Clin Transplant; 2010 Jun; 8(2):125-9. PubMed ID: 20565368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
    Olson KA; West K; McCarthy PL
    Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease.
    Sanders JE; Flournoy N; Thomas ED; Buckner CD; Lum LG; Clift RA; Appelbaum FR; Sullivan KM; Stewart P; Deeg HJ
    Med Pediatr Oncol; 1985; 13(4):165-72. PubMed ID: 3892260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant.
    Ruggeri A; Sun Y; Labopin M; Bacigalupo A; Lorentino F; Arcese W; Santarone S; Gülbas Z; Blaise D; Messina G; Ghavamzadeh A; Malard F; Bruno B; Diez-Martin JL; Koc Y; Ciceri F; Mohty M; Nagler A
    Haematologica; 2017 Feb; 102(2):401-410. PubMed ID: 27758821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogenic hair transplant in a bone marrow transplant recipient.
    Rosati P; Bergamo A
    Dermatol Surg; 1999 Aug; 25(8):664-5. PubMed ID: 10491051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction.
    Hymes SR; Morison WL; Farmer ER; Walters LL; Tutschka PJ; Santos GW
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):30-7. PubMed ID: 3980801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants.
    Ramsamooj R; Llull R; Black KS; Hewitt CW
    Plast Reconstr Surg; 1999 Oct; 104(5):1365-71. PubMed ID: 10513919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.
    Sullivan KM; Fefer A; Witherspoon R; Storb R; Buckner CD; Weiden P; Schoch G; Thomas ED
    Prog Clin Biol Res; 1987; 244():391-9. PubMed ID: 3310001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous graft-versus-host reaction lacks evidence of cutaneous cytomegalovirus by the immunoperoxidase technique.
    Horn TD; Farmer ER; Vogelsang GB; Wingard JR; Santos GW
    J Invest Dermatol; 1989 Jul; 93(1):92-5. PubMed ID: 2545790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor.
    Gajewski JL; Ippoliti C; Ma Y; Champlin R
    Am J Hematol; 2002 Dec; 71(4):311-3. PubMed ID: 12447962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.